7224933

Tocris Bioscience™ Idelalisib

Potent PI 3-Kinase δ isoform inhibitor

Manufacturer: Fischer Scientific

CAS Number: 870281-82-6

The price for this product is unavailable. Please request a quote

Chemical Name or Material

5-Fluoro-3-phenyl-2-[(1 S)-1-(9 H-purin-6-ylamino)propyl]-4(3 H)-quinazolinone

Target

PI 3-Kinase Inhibitors

Purity

98%

CAS

870281-82-6

Molecular Formula

C22H18FN7O

Other Options

Image Product Name Manufacturer Price Range
76-311-0
Tocris Bioscience™ Idelalisib
Fischer Scientific ₹ 7,716.30
76-315-0
Tocris Bioscience™ Idelalisib
Fischer Scientific ₹ 32,040.00
50-190-4775
Apexbio Technology LLC CAL-101 (Idelalisib, GS-1101), 20mg. Cas: 870281-82-6 MFCD: MFCD19443647. PI3K inhibitor
Apexbio Technology LLC ₹ 7,565.00
50-201-3598
Enzo Life Sciences Idelalisib (free base) (25mg). CAS: 870281-82-6
Enzo Life Sciences ₹ 20,572.35
50-860-7
Selleck Chemical LLC Idelalisib (CAL-101, GS-1101) 10mg 870281-82-6
Selleck Chemical LLC ₹ 15,699.60
50-860-8
Selleck Chemical LLC Idelalisib (CAL-101, GS-1101) 50mg 870281-82-6
Selleck Chemical LLC ₹ 49,359.40
50-190-4776
Apexbio Technology LLC CAL-101 (Idelalisib, GS-1101), 5mg. Cas: 870281-82-6 MFCD: MFCD19443647. PI3K inhibitor
Apexbio Technology LLC ₹ 4,717.00
NC0739757
Cayman Chemical CAL-101, 870281-82-6, 5 mg
Cayman Chemical ₹ 3,951.60
NC0877810
Selleck Chemical LLC Idelalisib (CAL-101, GS-1101) 10mM/1mL 870281-82-6
Selleck Chemical LLC ₹ 21,039.60
50-201-3600
Enzo Life Sciences Idelalisib (free base) (100mg). CAS: 870281-82-6
Enzo Life Sciences ₹ 53,603.81

Related Products

Img

Fischer Scientific

76-311-0

--

Img

Fischer Scientific

76-315-0

--

Img

Fischer Scientific

7223004

Potent VEGFR-2 inhibitor, also inhi...

Img

Fischer Scientific

74-971-0

--

Img

Fischer Scientific

74-975-0

--

Img

Fischer Scientific

78-651-0

--

Img

Fischer Scientific

78-655-0

--

Img

Tocris Bioscience™

561710

--

Description

  • Idelalisib is a potent PI 3-Kinase δ inhibitor (IC50 = 2.5 nM for p110δ); it exhibits >40-fold selectivity for the δ isoform over other PI 3-K class I enzymes (IC50s = 89, 565, and 820 nM for p110γ, p110β, and p110α respectively)
  • Idelalisib blocks constitutive PI 3-K signaling in malignant B-cell lines and primary patient tumor cells
  • Idelalisib inhibits chronic lymphocytic leukemia cell chemotaxis and downregulates chemokine secretion triggered by B-cell receptor signaling in stromal cocultures
  • Idelalisib lacks significant cytotoxicity toward natural killer (NK) cells
  • Idelalisib also decreases production of inflammatory cytokines, including TNF-γ, CD40L, and IL-6 by T cells and IFN-γ by NK cells
  • Idelalisib is cell-permeable and orally bioavailable.

SAFETY INFORMATION

  • Recommended Storage : Store at -20°C